Cartesian Therapeutics

Provide statistical leadership for clinical programs from protocol design through regulatory submission and post-marketing planning. Oversee external CROs and statistical vendors while shaping the analytical strategy for mRNA-engineered CAR-T cell therapies.

The Medical Director will serve as the sponsor medical monitor for clinical-stage autoimmune and cell therapy programs, providing medical oversight for Phase 1-3 trials. Key duties include protocol development, safety surveillance, and contributing medical expertise to regulatory documents and submissions.